Neuron23 Appoints Kathy Dong, Pharm.D., MBA to Board of Directors

/PRNewswire/ -- Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and...

Related Keywords

Nancy Stagliano ,Kathy Dong ,Gilead Sciences ,Rutgers University ,University Of New Mexico ,Bioverativ Inc ,Star Therapeutics ,True North ,New Mexico ,Neuron23 ,Biotechnology ,Health Care Amp Hospitals ,Pharmaceuticals ,Medical Pharmaceuticals ,Personnel Announcements ,